QPTFF (Quest PharmaTech) Beta: -1.2671 (As of Jul. 02, 2026)


What is Quest PharmaTech Beta?

Quest PharmaTech QPTFF Beta is -1.2671 as of Jul. 02, 2026.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-02), Quest PharmaTech's Beta is -1.2671.


Quest PharmaTech  (OTCPK:QPTFF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Quest PharmaTech Beta Related Terms


Quest PharmaTech Beta Historical Data

* Premium members only.

The historical data trend for Quest PharmaTech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech Beta Chart

Quest PharmaTech Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.00 -0.11 0.19 1.04

Quest PharmaTech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.29 0.60 0.88 1.04

QPTFF vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Quest PharmaTech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Beta distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Beta falls into.



Quest PharmaTech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -1.2671 mean?
Quest PharmaTech (QPTFF) has a Beta of -1.2671 as of Jul. 02, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Quest PharmaTech and its competitors.
Is Quest PharmaTech's Beta too high?
Quest PharmaTech's current Beta is -1.2671.
How does Quest PharmaTech's Beta compare to VRTX and REGN?
Quest PharmaTech's Beta of -1.2671 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Quest PharmaTech and its competitors. Quest PharmaTech's current Beta is -1.2671. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current Beta of -1.2671. The current Beta is -1.2671. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current Beta is -1.2671 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest PharmaTech Business Description

Other Exchanges QPT:Canada
Address 4342- 97 Street NW, Edmonton, AB, CAN, T6E 5R9
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.